Literature DB >> 33275739

What is the role for HSCT or immunotherapy in pediatric hypodiploid B-cell acute lymphoblastic leukemia?

Aimee C Talleur1, Shannon L Maude2,3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33275739      PMCID: PMC7727504          DOI: 10.1182/hematology.2020000162

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


× No keyword cloud information.
  10 in total

1.  Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels.

Authors:  Charles G Mullighan; Sima Jeha; Deqing Pei; Debbie Payne-Turner; Elaine Coustan-Smith; Kathryn G Roberts; Esmé Waanders; John K Choi; Xiaotu Ma; Susana C Raimondi; Yiping Fan; Wenjian Yang; Guangchun Song; Jun J Yang; Hiroto Inaba; James R Downing; Wing H Leung; W Paul Bowman; Mary V Relling; William E Evans; Jinghui Zhang; Dario Campana; Ching-Hon Pui
Journal:  Blood       Date:  2015-11-02       Impact factor: 22.113

2.  Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults.

Authors:  Rebecca A Gardner; Olivia Finney; Colleen Annesley; Hannah Brakke; Corinne Summers; Kasey Leger; Marie Bleakley; Christopher Brown; Stephanie Mgebroff; Karen S Kelly-Spratt; Virginia Hoglund; Catherine Lindgren; Assaf P Oron; Daniel Li; Stanley R Riddell; Julie R Park; Michael C Jensen
Journal:  Blood       Date:  2017-04-13       Impact factor: 22.113

3.  T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.

Authors:  Daniel W Lee; James N Kochenderfer; Maryalice Stetler-Stevenson; Yongzhi K Cui; Cindy Delbrook; Steven A Feldman; Terry J Fry; Rimas Orentas; Marianna Sabatino; Nirali N Shah; Seth M Steinberg; Dave Stroncek; Nick Tschernia; Constance Yuan; Hua Zhang; Ling Zhang; Steven A Rosenberg; Alan S Wayne; Crystal L Mackall
Journal:  Lancet       Date:  2014-10-13       Impact factor: 79.321

4.  Chimeric antigen receptor T cells for sustained remissions in leukemia.

Authors:  Shannon L Maude; Noelle Frey; Pamela A Shaw; Richard Aplenc; David M Barrett; Nancy J Bunin; Anne Chew; Vanessa E Gonzalez; Zhaohui Zheng; Simon F Lacey; Yolanda D Mahnke; Jan J Melenhorst; Susan R Rheingold; Angela Shen; David T Teachey; Bruce L Levine; Carl H June; David L Porter; Stephan A Grupp
Journal:  N Engl J Med       Date:  2014-10-16       Impact factor: 91.245

5.  Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia.

Authors:  Parinda A Mehta; Mei-Jie Zhang; Mary Eapen; Wensheng He; Adriana Seber; Brenda Gibson; Bruce M Camitta; Carrie L Kitko; Christopher C Dvorak; Eneida R Nemecek; Haydar A Frangoul; Hisham Abdel-Azim; Kimberly A Kasow; Leslie Lehmann; Marta Gonzalez Vicent; Miguel A Diaz Pérez; Mouhab Ayas; Muna Qayed; Paul A Carpenter; Sonata Jodele; Troy C Lund; Wing H Leung; Stella M Davies
Journal:  Biol Blood Marrow Transplant       Date:  2015-04-10       Impact factor: 5.742

6.  Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group.

Authors:  Jennifer L McNeer; Meenakshi Devidas; Yunfeng Dai; Andrew J Carroll; Nyla A Heerema; Julie M Gastier-Foster; Samir B Kahwash; Michael J Borowitz; Brent L Wood; Eric Larsen; Kelly W Maloney; Leonard Mattano; Naomi J Winick; Kirk R Schultz; Stephen P Hunger; William L Carroll; Mignon L Loh; Elizabeth A Raetz
Journal:  J Clin Oncol       Date:  2019-02-11       Impact factor: 50.717

7.  Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia.

Authors:  James B Nachman; Nyla A Heerema; Harland Sather; Bruce Camitta; Erik Forestier; Christine J Harrison; Nicole Dastugue; Martin Schrappe; Ching-Hon Pui; Giuseppe Basso; Lewis B Silverman; Gritta E Janka-Schaub
Journal:  Blood       Date:  2007-05-01       Impact factor: 22.113

8.  The genomic landscape of hypodiploid acute lymphoblastic leukemia.

Authors:  Linda Holmfeldt; Lei Wei; Ernesto Diaz-Flores; Michael Walsh; Jinghui Zhang; Li Ding; Debbie Payne-Turner; Michelle Churchman; Anna Andersson; Shann-Ching Chen; Kelly McCastlain; Jared Becksfort; Jing Ma; Gang Wu; Samir N Patel; Susan L Heatley; Letha A Phillips; Guangchun Song; John Easton; Matthew Parker; Xiang Chen; Michael Rusch; Kristy Boggs; Bhavin Vadodaria; Erin Hedlund; Christina Drenberg; Sharyn Baker; Deqing Pei; Cheng Cheng; Robert Huether; Charles Lu; Robert S Fulton; Lucinda L Fulton; Yashodhan Tabib; David J Dooling; Kerri Ochoa; Mark Minden; Ian D Lewis; L Bik To; Paula Marlton; Andrew W Roberts; Gordana Raca; Wendy Stock; Geoffrey Neale; Hans G Drexler; Ross A Dickins; David W Ellison; Sheila A Shurtleff; Ching-Hon Pui; Raul C Ribeiro; Meenakshi Devidas; Andrew J Carroll; Nyla A Heerema; Brent Wood; Michael J Borowitz; Julie M Gastier-Foster; Susana C Raimondi; Elaine R Mardis; Richard K Wilson; James R Downing; Stephen P Hunger; Mignon L Loh; Charles G Mullighan
Journal:  Nat Genet       Date:  2013-01-20       Impact factor: 38.330

9.  Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Retrospective Multinational Study.

Authors:  Ching-Hon Pui; Paola Rebora; Martin Schrappe; Andishe Attarbaschi; Andre Baruchel; Giuseppe Basso; Hélène Cavé; Sarah Elitzur; Katsuyoshi Koh; Hsi-Che Liu; Kajsa Paulsson; Rob Pieters; Lewis B Silverman; Jan Stary; Ajay Vora; Allen Yeoh; Christine J Harrison; Maria Grazia Valsecchi
Journal:  J Clin Oncol       Date:  2019-01-18       Impact factor: 50.717

10.  Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia.

Authors:  Deepa Bhojwani; Richard Sposto; Nirali N Shah; Vilmarie Rodriguez; Constance Yuan; Maryalice Stetler-Stevenson; Maureen M O'Brien; Jennifer L McNeer; Amrana Quereshi; Aurelie Cabannes; Paul Schlegel; Claudia Rossig; Luciano Dalla-Pozza; Keith August; Sarah Alexander; Jean-Pierre Bourquin; Michel Zwaan; Elizabeth A Raetz; Mignon L Loh; Susan R Rheingold
Journal:  Leukemia       Date:  2018-09-28       Impact factor: 11.528

  10 in total
  2 in total

Review 1.  Near-Haploidy and Low-Hypodiploidy in B-Cell Acute Lymphoblastic Leukemia: When Less Is Too Much.

Authors:  Oscar Molina; Alex Bataller; Namitha Thampi; Jordi Ribera; Isabel Granada; Pablo Velasco; José Luis Fuster; Pablo Menéndez
Journal:  Cancers (Basel)       Date:  2021-12-22       Impact factor: 6.639

Review 2.  Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children.

Authors:  Monika Lejman; Aleksandra Chałupnik; Zuzanna Chilimoniuk; Maciej Dobosz
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.